The New OPTN Kidney Allocation Policy: Potential for Inequitable Access Among Highly Sensitized Patients
Robert A. Bray(Emory University), Howard M. Gebel(Rush University Medical Center), Patricia Brannon(Emory University Hospital), Thomas C. Pearson(Emory Healthcare), Bruce Kaplan(University of Colorado Anschutz Medical Campus), Allan D. Kirk(University of Calgary), D.-F. Chen(Duke University), Charlene Breitenbach(Henrico Doctors' Hospital), Christopher Bryan, Jennifer Lai(California Pacific Medical Center), Tracy McRacken(Sentara Norfolk General Hospital)
Cited by 27
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Consensus Guidelines on the Testing and Clinical Management Issues Associated With HLA and Non-HLA Antibodies in Transplantation
|Transplantation|2012|777
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
Heterologous immunity provides a potent barrier to transplantation tolerance
|Journal of Clinical Investigation|2003|571